Walter-Bruckerhoff-Stiftung
Company Overview
Management
Laurens den Hollander
Zürich
Chairperson of the foundation board
Joint signing authority (any two to sign)
Daniel Tobler
Zürich
Member of the foundation board
Joint signing authority (any two to sign)
Dr. sc. ETH Zürich Carina Wolf
Schaffhausen
Member of the foundation board
Joint signing authority (any two to sign)
Johann Leendert den Hollander
Hünenberg
Chairperson of the foundation board
Joint signing authority (any two to sign)
Arthur Hunziker
Rüschlikon
Member of the foundation board
Joint signing authority (any two to sign)
Max Rieser
Thalwil
Member of the foundation board
Joint signing authority (any two to sign)
Max Rieser
Rüschlikon
Member of the foundation board
Joint signing authority (any two to sign)
Dr. Hunziker-Blum
Schaffhausen
Member of the foundation board
Joint signing authority (any two to sign)
Carina Derrer
Zürich
Member of the foundation board
Without signing authority
Daniel Tobler
Buchs (ZH)
Member of the foundation board
Joint signing authority (any two to sign)
Carina Derrer
Schaffhausen
Member of the foundation board
Joint signing authority (any two to sign)
Carina Wolf
Büsingen
Member of the foundation board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 16409 | 09.04.2025 | 72 | 14.04.2025 | 1006307923 |
| 2 | 52442 | 19.12.2023 | 249 | 22.12.2023 | 1005918112 |
| 3 | 37498 | 31.08.2021 | 171 | 03.09.2021 | 1005283496 |
| 4 | 26774 | 23.07.2018 | 143 | 26.07.2018 | 4382533 |
| 5 | 28946 | 16.08.2016 | 160 | 19.08.2016 | 3011007 |
| 6 | 21443 | 11.06.2009 | 114 | 17.06.2009 | 27/5072636 |
| 7 | 31564 | 13.12.2002 | 246 | 19.12.2002 | 26/780166 |
| 8 | 27001 | 29.10.2002 | 213 | 04.11.2002 | 17/712340 |
| 9 | 29809 | 14.11.2001 | 225 | 20.11.2001 | 9139 |
| 10 | 29832 | 13.12.2000 | 247 | 19.12.2000 | 8657 |
Company Purpose
Unterstützung der Krebsforschung, und zwar in dem Sinne, dass die Erträgnisse des Stiftungsvermögens der Krebsforschung dienen, je zur Hälfte in der Schweiz und in Holland. Die Stiftung kann ihre Zuwendungen anderen Organisationen mit gleichem Zweck zukommen lassen und ihre Aktionen mit solchen Organisationen koordinieren.